| 前收市價 | 6.40 |
| 開市 | 6.40 |
| 買盤 | 16.00 |
| 賣出價 | 20.70 |
| 拍板 | 65.00 |
| 到期日 | 2024-10-18 |
| 今日波幅 | 6.40 - 6.40 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 3 |
Insider MonkeyMultiple Headwinds Dragged Bio-Techne Corp. (TECH) in Q1
Conestoga Capital Advisors, an asset management company, released its “Mid-Cap Strategy” first-quarter 2024 investor letter. A copy of the letter can be downloaded here. It was a solid quarter as many asset classes moved higher. The S&P Index, which tracks the performance of large-cap stocks, reached an all-time high on March 28th, and the Russell 2000 […]
InvestorPlace7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
Fundamentally, one of the biggest advantages of biotech stocks to buy centers on the underlying prioritization. While the media focuses on attaining wealth, that doesn’t mean much if you don’t have health. Therefore, this compelling subcategory of the broader healthcare market deserves attention. In addition, while the market has been robust – with the Dow Jones Industrial Average breaching the 40,000-point level – many concerns exist. Inflation remains elevated as are borrowing costs. Delinquen
Insider MonkeyBio-Techne Corporation (TECH) Declined on Weak Q4 Results
Baron Funds, an investment management company, released its “Baron Asset Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here. US markets continued its strong rally in the first quarter. Robust economic data and relatively strong corporate earnings boosted the rally along with the anticipation of a soft landing of […]
